{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T16:06:57Z","timestamp":1793203617547,"version":"4.5.0"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,6,16]],"date-time":"2021-06-16T00:00:00Z","timestamp":1623801600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,6,16]],"date-time":"2021-06-16T00:00:00Z","timestamp":1623801600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Musculoskelet Disord"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Intra-articular (IA) corticosteroid (CS) injections are the mainstay of treatment for symptomatic management in knee osteoarthritis (OA), particularly in the UK. IA platelet-rich plasma (PRP) injections are a promising alternative, but no systematic reviews to date have compared them to the current standard of care, IA CS injections. We aim to investigate the effect of IA PRP injections versus IA corticosteroid injections for the symptomatic management of knee OA.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>All published trials comparing IA PRP and CS injections for knee OA were included. MEDLINE, EMBASE, Scopus and Web of Science were searched through June 2020. Risk of bias was assessed using the Cochrane Risk of Bias tool. A random effects model was used to calculate standardized mean difference with 95% confidence interval in WOMAC\/VAS score (or subscores), comparing IA PRP to CS injections across studies.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Included were eight studies and 648 patients, 443 (68%) were female, mean age 59\u2009years, with a mean BMI of 28.4. Overall, the studies were considered at low risk of bias. Compared with CS injections, PRP was significantly better in reducing OA symptoms (pain, stiffness, functionality) at 3, 6 and 9\u2009months post-intervention (<jats:italic>P\u2009&lt;\u20090.01<\/jats:italic>). The greatest effect was observed at 6 and 9\u2009months (\u2212\u20090.78 (\u2212\u20091.34 to \u2212\u20090.23) standard mean deviations (SMD) and\u2009\u2212\u20091.63 (\u2212\u20092.14 to \u2212\u20091.12) SMD respectively). At 6 months, this equates to an additional reduction of 9.51 in WOMAC or 0.97 on the VAS pain scales. At 6 months PRP allowed greater return to sporting activities than CS, measured by the KOOS subscale for sporting activity, of magnitude 9.7 (\u2212\u20090.45 to 19.85) (<jats:italic>P\u2009=\u20090.06<\/jats:italic>). Triple injections of PRP, generally separated by a week, were superior to single injections over 12\u2009months follow-up (<jats:italic>P\u2009&lt;\u20090.01<\/jats:italic>).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>IA-PRP injections produce superior outcomes when compared with CS injections for symptomatic management of knee OA, including improved pain management, less joint stiffness and better participation in exercise\/sporting activity at 12\u2009months follow-up. Giving three IA-PRP, with injections separated by a week, appears more effective than 1 IA-PRP injection.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Prospero trial registration number<\/jats:title>\n                <jats:p><jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/www.crd.york.ac.uk\/prospero\/display_record.php?RecordID=181928\">CRD42020181928<\/jats:ext-link>.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12891-021-04308-3","type":"journal-article","created":{"date-parts":[[2021,6,16]],"date-time":"2021-06-16T19:02:46Z","timestamp":1623870166000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":91,"title":["Intra-articular platelet-rich plasma injections versus intra-articular corticosteroid injections for symptomatic management of knee osteoarthritis: systematic review and meta-analysis"],"prefix":"10.1186","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9478-8569","authenticated-orcid":false,"given":"Michael","family":"McLarnon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4123-9806","authenticated-orcid":false,"given":"Neil","family":"Heron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,6,16]]},"reference":[{"issue":"1","key":"4308_CR1","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1186\/1471-2474-11-144","volume":"11","author":"KP Jordan","year":"2010","unstructured":"Jordan KP, Kadam UT, Hayward R, Porcheret M, Young C, Croft P. Annual consultation prevalence of regional musculoskeletal problems in primary care: an observational study. BMC Musculoskelet Disord. 2010;11(1):144. https:\/\/doi.org\/10.1186\/1471-2474-11-144.","journal-title":"BMC Musculoskelet Disord"},{"issue":"1","key":"4308_CR2","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s12963-017-0130-8","volume":"15","author":"HC Boshuizen","year":"2017","unstructured":"Boshuizen HC, Poos MJJC, van den Akker M, van Boven K, Korevaar JC, de Waal MWM, et al. Estimating incidence and prevalence rates of chronic diseases using disease modeling. Popul Health Metrics. 2017;15(1):13. https:\/\/doi.org\/10.1186\/s12963-017-0130-8.","journal-title":"Popul Health Metrics"},{"key":"4308_CR3","doi-asserted-by":"crossref","unstructured":"Heron N, Ryans I. What Musculoskeletal (MSK) Conditions are Referred from Routine General Practice (GP) and what Impact does this have on Developing Innovative Care Models for Patients with MSK Conditions in Primary Care? Int J Phys Med Rehabil. 2016;4(06).","DOI":"10.4172\/2329-9096.1000375"},{"issue":"7","key":"4308_CR4","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1136\/annrheumdis-2013-204763","volume":"73","author":"M Cross","year":"2014","unstructured":"Cross M, Smith E, Hoy D, Nolte S, Ackerman I, Fransen M, et al. The global burden of hip and knee osteoarthritis: estimates from the global burden of disease 2010 study. Ann Rheum Dis. 2014;73(7):1323\u201330. https:\/\/doi.org\/10.1136\/annrheumdis-2013-204763.","journal-title":"Ann Rheum Dis"},{"key":"4308_CR5","doi-asserted-by":"crossref","unstructured":"GBD2017 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990\u20132017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392(10159):1789\u2013858.","DOI":"10.1016\/S0140-6736(18)32279-7"},{"issue":"8","key":"4308_CR6","doi-asserted-by":"publisher","first-page":"635","DOI":"10.7326\/0003-4819-133-8-200010170-00016","volume":"133","author":"DT Felson","year":"2000","unstructured":"Felson DT, Lawrence RC, Dieppe PA, Hirsch R, Helmick CG, Jordan JM, et al. Osteoarthritis: new insights. Part 1: the disease and its risk factors. Ann Intern Med. 2000;133(8):635\u201346. https:\/\/doi.org\/10.7326\/0003-4819-133-8-200010170-00016.","journal-title":"Ann Intern Med"},{"key":"4308_CR7","volume-title":"Osteoarthritis: care and management in adults","author":"National CGCU","year":"2014","unstructured":"National CGCU. Osteoarthritis: care and management in adults. 2014."},{"issue":"11","key":"4308_CR8","doi-asserted-by":"publisher","first-page":"1648","DOI":"10.1016\/j.joca.2013.08.003","volume":"21","author":"JA Wallis","year":"2013","unstructured":"Wallis JA, Webster KE, Levinger P, Taylor NF. What proportion of people with hip and knee osteoarthritis meet physical activity guidelines? A systematic review and meta-analysis. Osteoarthr Cartil. 2013;21(11):1648\u201359. https:\/\/doi.org\/10.1016\/j.joca.2013.08.003.","journal-title":"Osteoarthr Cartil"},{"key":"4308_CR9","unstructured":"Harrison A, Appleby J. The war on waiting for hospital treatment: what has labour achieved and what challenges remain: summary: King's Fund; 2005."},{"key":"4308_CR10","doi-asserted-by":"publisher","first-page":"l6237","DOI":"10.1136\/bmj.l6237","volume":"367","author":"J Appleby","year":"2019","unstructured":"Appleby J. Waiting times compared across the four UK nations. BMJ. 2019;367:l6237.","journal-title":"BMJ."},{"issue":"9","key":"4308_CR11","doi-asserted-by":"publisher","first-page":"2227","DOI":"10.1007\/s11136-018-1846-z","volume":"27","author":"J Morris","year":"2018","unstructured":"Morris J, Twizeyemariya A, Grimmer K. What is the current evidence of the impact on quality of life whilst waiting for management\/treatment of orthopaedic\/musculoskeletal complaints? A systematic scoping review. Qual Life Res. 2018;27(9):2227\u201342. https:\/\/doi.org\/10.1007\/s11136-018-1846-z.","journal-title":"Qual Life Res"},{"key":"4308_CR12","doi-asserted-by":"crossref","unstructured":"Juni P, Hari R, Rutjes AW, Fischer R, Silletta MG, Reichenbach S, et al. Intra-articular corticosteroid for knee osteoarthritis. Cochrane Database Syst Rev. 2015;10(10):1\u201380. https:\/\/www.cochranelibrary.com\/cdsr\/doi\/10.1002\/14651858.CD005328.pub3\/epdf\/full.","DOI":"10.1002\/14651858.CD005328.pub3"},{"issue":"19","key":"4308_CR13","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.1001\/jama.2017.5283","volume":"317","author":"TE McAlindon","year":"2017","unstructured":"McAlindon TE, LaValley MP, Harvey WF, Price LL, Driban JB, Zhang M, et al. Effect of intra-articular triamcinolone vs saline on knee cartilage volume and pain in patients with knee osteoarthritis: a randomized clinical trial. JAMA. 2017;317(19):1967\u201375. https:\/\/doi.org\/10.1001\/jama.2017.5283.","journal-title":"JAMA."},{"issue":"9","key":"4308_CR14","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1007\/s00167-011-1820-6","volume":"20","author":"JL Dragoo","year":"2012","unstructured":"Dragoo JL, Danial CM, Braun HJ, Pouliot MA, Kim HJ. The chondrotoxicity of single-dose corticosteroids. Knee Surg Sports Traumatol Arthrosc. 2012;20(9):1809\u201314. https:\/\/doi.org\/10.1007\/s00167-011-1820-6.","journal-title":"Knee Surg Sports Traumatol Arthrosc"},{"issue":"6","key":"4308_CR15","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1016\/j.joca.2019.01.007","volume":"27","author":"C Zeng","year":"2019","unstructured":"Zeng C, Lane NE, Hunter DJ, Wei J, Choi HK, McAlindon TE, et al. Intra-articular corticosteroids and the risk of knee osteoarthritis progression: results from the osteoarthritis initiative. Osteoarthr Cartil. 2019;27(6):855\u201362. https:\/\/doi.org\/10.1016\/j.joca.2019.01.007.","journal-title":"Osteoarthr Cartil"},{"issue":"3","key":"4308_CR16","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1016\/j.arthro.2016.09.024","volume":"33","author":"WL Dai","year":"2017","unstructured":"Dai WL, Zhou AG, Zhang H, Zhang J. Efficacy of Platelet-Rich Plasma in the Treatment of Knee Osteoarthritis: A Meta-analysis of Randomized Controlled Trials. Arthroscopy. 2017;33(3):659\u201370 e1.","journal-title":"Arthroscopy"},{"issue":"3","key":"4308_CR17","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/j.arthro.2015.08.005","volume":"32","author":"CJ Meheux","year":"2016","unstructured":"Meheux CJ, McCulloch PC, Lintner DM, Varner KE, Harris JD. Efficacy of intra-articular platelet-rich plasma injections in knee osteoarthritis: a systematic review. Arthroscopy. 2016;32(3):495\u2013505. https:\/\/doi.org\/10.1016\/j.arthro.2015.08.005.","journal-title":"Arthroscopy"},{"issue":"1","key":"4308_CR18","doi-asserted-by":"publisher","first-page":"138","DOI":"10.4103\/2277-9175.135156","volume":"3","author":"A Kabiri","year":"2014","unstructured":"Kabiri A, Esfandiari E, Esmaeili A, Hashemibeni B, Pourazar A, Mardani M. Platelet-rich plasma application in chondrogenesis. Adv Biomed Res. 2014;3(1):138.","journal-title":"Adv Biomed Res"},{"issue":"1","key":"4308_CR19","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1177\/0363546513507766","volume":"42","author":"EA Sundman","year":"2014","unstructured":"Sundman EA, Cole BJ, Karas V, Della Valle C, Tetreault MW, Mohammed HO, et al. The anti-inflammatory and matrix restorative mechanisms of platelet-rich plasma in osteoarthritis. Am J Sports Med. 2014;42(1):35\u201341. https:\/\/doi.org\/10.1177\/0363546513507766.","journal-title":"Am J Sports Med"},{"issue":"3","key":"4308_CR20","doi-asserted-by":"publisher","first-page":"273","DOI":"10.5606\/ArchRheumatol.2018.6608","volume":"33","author":"E Uslu Guvendi","year":"2018","unstructured":"Uslu Guvendi E, Askin A, Guvendi G, Kocyigit H. Comparison of efficiency between corticosteroid and platelet rich plasma injection therapies in patients with knee osteoarthritis. Arch Rheumatol. 2018;33(3):273\u201381.","journal-title":"Arch Rheumatol"},{"issue":"3","key":"4308_CR21","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1007\/s00167-015-3705-6","volume":"25","author":"G G\u00f6rmeli","year":"2017","unstructured":"G\u00f6rmeli G, G\u00f6rmeli CA, Ataoglu B, \u00c7olak C, Aslant\u00fcrk O, Ertem K. Multiple PRP injections are more effective than single injections and hyaluronic acid in knees with early osteoarthritis: a randomized, double-blind, placebo-controlled trial. Knee Surg Sports Traumatol Arthrosc. 2017;25(3):958\u201365. https:\/\/doi.org\/10.1007\/s00167-015-3705-6.","journal-title":"Knee Surg Sports Traumatol Arthrosc"},{"issue":"2","key":"4308_CR22","doi-asserted-by":"crossref","first-page":"232596711668938","DOI":"10.1177\/2325967116689386","volume":"5","author":"N Joshi Jubert","year":"2017","unstructured":"Joshi Jubert N, Rodr\u00edguez L, Revert\u00e9-Vinaixa MM, Navarro A. Platelet-Rich Plasma Injections for Advanced Knee Osteoarthritis: A Prospective, Randomized, Double-Blinded Clinical Trial. Orthop J Sports Med. 2017;5(2):2325967116689386.","journal-title":"Orthop J Sports Med"},{"issue":"3","key":"4308_CR23","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1177\/0363546515580787","volume":"44","author":"JC Riboh","year":"2016","unstructured":"Riboh JC, Saltzman BM, Yanke AB, Fortier L, Cole BJ. Effect of leukocyte concentration on the efficacy of platelet-rich plasma in the treatment of knee osteoarthritis. Am J Sports Med. 2016;44(3):792\u2013800. https:\/\/doi.org\/10.1177\/0363546515580787.","journal-title":"Am J Sports Med"},{"issue":"7","key":"4308_CR24","doi-asserted-by":"publisher","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","volume":"6","author":"D Moher","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG, The PG. Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. PLoS Med. 2009;6(7):e1000097. https:\/\/doi.org\/10.1371\/journal.pmed.1000097.","journal-title":"PLoS Med"},{"issue":"1","key":"4308_CR25","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/1471-2288-5-13","volume":"5","author":"SP Hozo","year":"2005","unstructured":"Hozo SP, Djulbegovic B, Hozo I. Estimating the mean and variance from the median, range, and the size of a sample. BMC Med Res Methodol. 2005;5(1):13. https:\/\/doi.org\/10.1186\/1471-2288-5-13.","journal-title":"BMC Med Res Methodol"},{"key":"4308_CR26","doi-asserted-by":"crossref","unstructured":"Huang Y, Liu X, Xu X, Liu J. Intra-articular injections of platelet-rich plasma, hyaluronic acid or corticosteroids for knee osteoarthritis: A prospective randomized controlled study. Orthopade. 2019;48(3):239\u201347.","DOI":"10.1007\/s00132-018-03659-5"},{"key":"4308_CR27","unstructured":"Phul SH, Mobushir M, Jilani RUA, Khan IS, Malik RH, Jan G. Comparison of Intra-Articular Steroids Injection Versus Platelets Rich Plasma Injection in Patients with Osteoarthritic Knee Joints; 2018."},{"key":"4308_CR28","doi-asserted-by":"crossref","unstructured":"Freire MRdM, da Silva PMC, Azevedo AR, Silva DS, da Silva RBB, Cardoso JC. Comparative effect between infiltration of platelet-rich plasma and the use of corticosteroids in the treatment of knee osteoarthritis: a prospective and randomized clinical trial. Revista Brasileira de Ortopedia. 2020;55(5):551\u20136.","DOI":"10.1016\/j.rbo.2018.01.001"},{"key":"4308_CR29","unstructured":"KHAN AF, GILLANI SFUHS, Khan AF. Role of Intra-Articular Corticosteroid with Xylocaine Vs Plate Rich Plasma for the Treatment of Early Grade II Knee Osteoarthritis at Akhtar Saeed Teaching Hospital Lahore: A Randomized Controlled Trail. 2018."},{"key":"4308_CR30","doi-asserted-by":"crossref","unstructured":"Naderi NB, Sedighinejad A, Mardani-Kivi M, Haghighi M, Atrkar Roushan Z, Ghazanfar Tehran S, Biazar G. Comparing the effectiveness of intraarticular platelet-rich plasma and corticosteroid injection under ultrasound guidance on pain control of knee osteoarthritis. Iranian Red Crescent M J. 2018;20(3).","DOI":"10.5812\/ircmj.62157"},{"key":"4308_CR31","doi-asserted-by":"crossref","unstructured":"Camurcu Y, Sofu H, Ucpunar H, Kockara N, Cobden A, Duman S: Single-dose intra-articular corticosteroid injection prior to platelet-rich plasma injection resulted in better clinical outcomes in patients with knee osteoarthritis: A pilot study. J Back Musculoskeletal Rehabilitation. 2018;31(4):603\u201310.","DOI":"10.3233\/BMR-171066"},{"key":"4308_CR32","doi-asserted-by":"crossref","unstructured":"McGuinness L, Higgins J. Risk-of-Bias VISualization (robvis): an R package and shiny web app for visualizing risk-of-bias assessments. Res Synth Methods. 2020.","DOI":"10.1002\/jrsm.1411"},{"issue":"3","key":"4308_CR33","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1016\/j.apmr.2013.11.006","volume":"95","author":"KV Chang","year":"2014","unstructured":"Chang KV, Hung CY, Aliwarga F, Wang TG, Han DS, Chen WS. Comparative effectiveness of platelet-rich plasma injections for treating knee joint cartilage degenerative pathology: a systematic review and meta-analysis. Arch Phys Med Rehabil. 2014;95(3):562\u201375. https:\/\/doi.org\/10.1016\/j.apmr.2013.11.006.","journal-title":"Arch Phys Med Rehabil"},{"issue":"1","key":"4308_CR34","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s13018-017-0521-3","volume":"12","author":"L Shen","year":"2017","unstructured":"Shen L, Yuan T, Chen S, Xie X, Zhang C. The temporal effect of platelet-rich plasma on pain and physical function in the treatment of knee osteoarthritis: systematic review and meta-analysis of randomized controlled trials. J Orthop Surg Res. 2017;12(1):16. https:\/\/doi.org\/10.1186\/s13018-017-0521-3.","journal-title":"J Orthop Surg Res"},{"key":"4308_CR35","doi-asserted-by":"publisher","first-page":"63X 646","DOI":"10.5435\/00124635-200910000-00006","volume":"17","author":"CT Hepper","year":"2009","unstructured":"Hepper CT, Halvorson JJ, Duncan ST, Gregory AJM, Dunn WR, Spindler KP. The Efficacy and Duration of Intr\u00c5 articular Corticosteroid Injection for Knee Osteoarthritis: A Systematic Review of Level I Studies. J Am Acad Orthop Surg. 2009;17:63X 646.","journal-title":"J Am Acad Orthop Surg"},{"issue":"10","key":"4308_CR36","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1136\/bjsports-2019-101250","volume":"54","author":"JW Orchard","year":"2020","unstructured":"Orchard JW. Corticosteroid injections: glass half-full, half-empty or full then empty? Br J Sports Med. 2020;54(10):564\u20135. https:\/\/doi.org\/10.1136\/bjsports-2019-101250.","journal-title":"Br J Sports Med"},{"issue":"4","key":"4308_CR37","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1007\/s00167-010-1238-6","volume":"19","author":"G Filardo","year":"2011","unstructured":"Filardo G, Kon E, Buda R, Timoncini A, Di Martino A, Cenacchi A, et al. Platelet-rich plasma intra-articular knee injections for the treatment of degenerative cartilage lesions and osteoarthritis. Knee Surg Sports Traumatol Arthrosc. 2011;19(4):528\u201335. https:\/\/doi.org\/10.1007\/s00167-010-1238-6.","journal-title":"Knee Surg Sports Traumatol Arthrosc"},{"issue":"5","key":"4308_CR38","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1007\/s00590-012-1037-5","volume":"23","author":"SJ Jang","year":"2013","unstructured":"Jang SJ, Kim JD, Cha SS. Platelet-rich plasma (PRP) injections as an effective treatment for early osteoarthritis. Eur J Orthop Surg Traumatol. 2013;23(5):573\u201380. https:\/\/doi.org\/10.1007\/s00590-012-1037-5.","journal-title":"Eur J Orthop Surg Traumatol"},{"issue":"5","key":"4308_CR39","doi-asserted-by":"publisher","first-page":"e97293","DOI":"10.1371\/journal.pone.0097293","volume":"9","author":"J Liu","year":"2014","unstructured":"Liu J, Song W, Yuan T, Xu Z, Jia W, Zhang C. A comparison between platelet-rich plasma (PRP) and hyaluronate acid on the healing of cartilage defects. PLoS One. 2014;9(5):e97293. https:\/\/doi.org\/10.1371\/journal.pone.0097293.","journal-title":"PLoS One"},{"issue":"4","key":"4308_CR40","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1007\/s00167-009-0940-8","volume":"18","author":"E Kon","year":"2010","unstructured":"Kon E, Buda R, Filardo G, Di Martino A, Timoncini A, Cenacchi A, et al. Platelet-rich plasma: intra-articular knee injections produced favorable results on degenerative cartilage lesions. Knee Surg Sports Traumatol Arthrosc. 2010;18(4):472\u20139. https:\/\/doi.org\/10.1007\/s00167-009-0940-8.","journal-title":"Knee Surg Sports Traumatol Arthrosc"},{"issue":"1","key":"4308_CR41","doi-asserted-by":"publisher","first-page":"230949901988766","DOI":"10.1177\/2309499019887660","volume":"28","author":"Q Wu","year":"2020","unstructured":"Wu Q, Luo X, Xiong Y, Liu G, Wang J, Chen X, et al. Platelet-rich plasma versus hyaluronic acid in knee osteoarthritis: a meta-analysis with the consistent ratio of injection. J Orthop Surg. 2020;28(1):2309499019887660. https:\/\/doi.org\/10.1177\/2309499019887660.","journal-title":"J Orthop Surg"},{"key":"4308_CR42","doi-asserted-by":"publisher","unstructured":"Angst F, Aeschlimann A, Stucki G. Smallest detectable and minimal clinically important differences of rehabilitation intervention with their implications for required sample sizes using WOMAC and SF-36 quality of life measurement instruments in patients with osteoarthritis of the lower extremities. Arthritis Care Res. 2001;45(4):384\u201391. https:\/\/doi.org\/10.1002\/1529-0131(200108)45:4<384::AID-ART352>3.0.CO;2-0.","DOI":"10.1002\/1529-0131(200108)45:4<384::AID-ART352>3.0.CO;2-0"},{"issue":"13","key":"4308_CR43","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1136\/bjsports-2018-100231","volume":"54","author":"JM Schulz","year":"2020","unstructured":"Schulz JM, Birmingham TB, Atkinson HF, Woehrle E, Primeau CA, Lukacs MJ, et al. Are we missing the target? Are we aiming too low? What are the aerobic exercise prescriptions and their effects on markers of cardiovascular health and systemic inflammation in patients with knee osteoarthritis? A systematic review and meta-analysis. Br J Sports Med. 2020;54(13):771\u20135. https:\/\/doi.org\/10.1136\/bjsports-2018-100231.","journal-title":"Br J Sports Med"},{"key":"4308_CR44","doi-asserted-by":"publisher","unstructured":"Guidelines ACoRSoO. Recommendations for the medical management of osteoarthritis of the hip and knee: 2000 update. Arthritis Rheum. 2000;43(9):1905\u201315. https:\/\/doi.org\/10.1002\/1529-0131(200009)43:9<1905::AID-ANR1>3.0.CO;2-P.","DOI":"10.1002\/1529-0131(200009)43:9<1905::AID-ANR1>3.0.CO;2-P"},{"issue":"1","key":"4308_CR45","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.joca.2004.10.008","volume":"13","author":"R Christensen","year":"2005","unstructured":"Christensen R, Astrup A, Bliddal H. Weight loss: the treatment of choice for knee osteoarthritis? A randomized trial. Osteoarthr Cartil. 2005;13(1):20\u20137. https:\/\/doi.org\/10.1016\/j.joca.2004.10.008.","journal-title":"Osteoarthr Cartil"},{"issue":"Suppl 1","key":"4308_CR46","doi-asserted-by":"publisher","first-page":"S7","DOI":"10.1016\/j.jcot.2019.05.008","volume":"10","author":"JF Lana","year":"2019","unstructured":"Lana JF, Huber SC, Purita J, Tambeli CH, Santos GS, Paulus C, et al. Leukocyte-rich PRP versus leukocyte-poor PRP - The role of monocyte\/macrophage function in the healing cascade. J Clin Orthop Trauma. 2019;10(Suppl 1):S7\u2013S12. https:\/\/doi.org\/10.1016\/j.jcot.2019.05.008.","journal-title":"J Clin Orthop Trauma"},{"issue":"4","key":"4308_CR47","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1007\/s12178-018-9527-7","volume":"11","author":"ADK Le","year":"2018","unstructured":"Le ADK, Enweze L, DeBaun MR, Dragoo JL. Current clinical recommendations for use of platelet-rich plasma. Curr Rev Musculoskelet Med. 2018;11(4):624\u201334. https:\/\/doi.org\/10.1007\/s12178-018-9527-7.","journal-title":"Curr Rev Musculoskelet Med"},{"issue":"11","key":"4308_CR48","doi-asserted-by":"publisher","first-page":"2213","DOI":"10.1016\/j.arthro.2015.03.041","volume":"31","author":"KA Campbell","year":"2015","unstructured":"Campbell KA, Saltzman BM, Mascarenhas R, Khair MM, Verma NN, Bach BR Jr, et al. Does intra-articular platelet-rich plasma injection provide clinically superior outcomes compared with other therapies in the treatment of knee osteoarthritis? A systematic review of overlapping meta-analyses. Arthroscopy. 2015;31(11):2213\u201321. https:\/\/doi.org\/10.1016\/j.arthro.2015.03.041.","journal-title":"Arthroscopy."},{"issue":"2","key":"4308_CR49","doi-asserted-by":"publisher","first-page":"78","DOI":"10.5336\/medsci.2014-42651","volume":"35","author":"A Orscelik","year":"2015","unstructured":"Orscelik A, Yildiz Y. Comparison of single and triple platelet rich plasma injections in the treatment of Patellofemoral pain syndrome. Turk Klin J Med Sci. 2015;35(2):78\u201387. https:\/\/doi.org\/10.5336\/medsci.2014-42651.","journal-title":"Turk Klin J Med Sci"},{"issue":"12","key":"4308_CR50","doi-asserted-by":"crossref","first-page":"232596711988711","DOI":"10.1177\/2325967119887116","volume":"7","author":"F Vilchez-Cavazos","year":"2019","unstructured":"Vilchez-Cavazos F, Mill\u00e1n-Alan\u00eds JM, Bl\u00e1zquez-Salda\u00f1a J, \u00c1lvarez-Villalobos N, Pe\u00f1a-Mart\u00ednez VM, Acosta-Olivo CA, et al. Comparison of the Clinical Effectiveness of Single Versus Multiple Injections of Platelet-Rich Plasma in the Treatment of Knee Osteoarthritis: A Systematic Review and Meta-analysis. Orthop J Sports Med. 2019;7(12):2325967119887116.","journal-title":"Orthop J Sports Med"},{"issue":"10","key":"4308_CR51","doi-asserted-by":"publisher","first-page":"2300","DOI":"10.1177\/0363546519856605","volume":"47","author":"DK Chouhan","year":"2019","unstructured":"Chouhan DK, Dhillon MS, Patel S, Bansal T, Bhatia A, Kanwat H. Multiple platelet-rich plasma injections versus single platelet-rich plasma injection in early osteoarthritis of the knee: an experimental study in a Guinea pig model of early knee osteoarthritis. Am J Sports Med. 2019;47(10):2300\u20137. https:\/\/doi.org\/10.1177\/0363546519856605.","journal-title":"Am J Sports Med"},{"issue":"11","key":"4308_CR52","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1016\/j.arthro.2011.05.011","volume":"27","author":"E Kon","year":"2011","unstructured":"Kon E, Mandelbaum B, Buda R, Filardo G, Delcogliano M, Timoncini A, et al. Platelet-rich plasma intra-articular injection versus hyaluronic acid Viscosupplementation as treatments for cartilage pathology: from early degeneration to osteoarthritis. Arthroscopy. 2011;27(11):1490\u2013501. https:\/\/doi.org\/10.1016\/j.arthro.2011.05.011.","journal-title":"Arthroscopy"},{"issue":"3","key":"4308_CR53","doi-asserted-by":"publisher","first-page":"5405","DOI":"10.4081\/or.2014.5405","volume":"6","author":"SM Rayegani","year":"2014","unstructured":"Rayegani SM, Raeissadat SA, Taheri MS, Babaee M, Bahrami MH, Eliaspour D, et al. Does intra articular platelet rich plasma injection improve function, pain and quality of life in patients with osteoarthritis of the knee? A randomized clinical trial. Orthop Rev (Pavia). 2014;6(3):5405.","journal-title":"Orthop Rev (Pavia)"},{"issue":"3","key":"4308_CR54","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1080\/08977190600821327","volume":"24","author":"PAM Everts","year":"2006","unstructured":"Everts PAM, Brown Mahoney C, Hoffmann JJML, Sch\u00f6nberger JPAM, Box HAM, van Zundert A, et al. Platelet-rich plasma preparation using three devices: implications for platelet activation and platelet growth factor release. Growth Factors. 2006;24(3):165\u201371. https:\/\/doi.org\/10.1080\/08977190600821327.","journal-title":"Growth Factors"},{"issue":"4","key":"4308_CR55","doi-asserted-by":"publisher","first-page":"189","DOI":"10.4103\/0974-2077.150734","volume":"7","author":"R Dhurat","year":"2014","unstructured":"Dhurat R, Sukesh M. Principles and methods of preparation of platelet-rich plasma: a review and Author's perspective. J Cutan Aesthet Surg. 2014;7(4):189\u201397. https:\/\/doi.org\/10.4103\/0974-2077.150734.","journal-title":"J Cutan Aesthet Surg"},{"issue":"4","key":"4308_CR56","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1177\/1947603516670709","volume":"8","author":"L Laver","year":"2017","unstructured":"Laver L, Marom N, Dnyanesh L, Mei-Dan O, Espregueira-Mendes J, Gobbi A. PRP for degenerative cartilage disease: a systematic review of clinical studies. Cartilage. 2017;8(4):341\u201364. https:\/\/doi.org\/10.1177\/1947603516670709.","journal-title":"Cartilage."},{"issue":"4","key":"4308_CR57","doi-asserted-by":"publisher","first-page":"308","DOI":"10.2106\/JBJS.K.00430","volume":"94","author":"AD Mazzocca","year":"2012","unstructured":"Mazzocca AD, McCarthy MBR, Chowaniec DM, Cote MP, Romeo AA, Bradley JP, et al. Platelet-rich plasma differs according to preparation method and human variability. JBJS. 2012;94(4):308\u201316. https:\/\/doi.org\/10.2106\/JBJS.K.00430.","journal-title":"JBJS."},{"issue":"7","key":"4308_CR58","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1136\/jcp.2004.022129","volume":"58","author":"H Mani","year":"2005","unstructured":"Mani H, Luxembourg B, Kl\u00e4ffling C, Erbe M, Lindhoff-Last E. Use of native or platelet count adjusted platelet rich plasma for platelet aggregation measurements. J Clin Pathol. 2005;58(7):747\u201350. https:\/\/doi.org\/10.1136\/jcp.2004.022129.","journal-title":"J Clin Pathol"},{"issue":"6","key":"4308_CR59","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.2106\/JBJS.H.00246","volume":"91","author":"B Han","year":"2009","unstructured":"Han B, Woodell-May J, Ponticiello M, Yang Z, Nimni M. The effect of thrombin activation of platelet-rich plasma on demineralized bone matrix osteoinductivity. J Bone Joint Surg Am. 2009;91(6):1459\u201370. https:\/\/doi.org\/10.2106\/JBJS.H.00246.","journal-title":"J Bone Joint Surg Am"},{"key":"4308_CR60","doi-asserted-by":"crossref","unstructured":"Chahla J, Cinque ME, Piuzzi NS, Mannava S, Geeslin AG, Murray IR, et al. A Call for Standardization in Platelet-Rich Plasma Preparation Protocols and Composition Reporting: A Systematic Review of the Clinical Orthopaedic Literature. JBJS. 2017;99(20).","DOI":"10.2106\/JBJS.16.01374"}],"container-title":["BMC Musculoskeletal Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12891-021-04308-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12891-021-04308-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12891-021-04308-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,16]],"date-time":"2021-06-16T19:03:15Z","timestamp":1623870195000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmusculoskeletdisord.biomedcentral.com\/articles\/10.1186\/s12891-021-04308-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,16]]},"references-count":60,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["4308"],"URL":"https:\/\/doi.org\/10.1186\/s12891-021-04308-3","relation":{},"ISSN":["1471-2474"],"issn-type":[{"value":"1471-2474","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,16]]},"assertion":[{"value":"13 September 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"550"}}